Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (411-420 of 430) with videos related to

Pageof 43
Sort By:
Nature Medicine|February 5, 2008
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationNathan W Bartlett, Ross P Walton, Michael R Edwards, et al.
Allergy|June 3, 2020
EAACI Biologicals Guidelines-Recommendations for severe asthmaIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|February 9, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Jessica Beltran, Cezmi Akdis, et al.
Allergy|March 11, 2020
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthmaIoana Agache, Yang Song, Claudio Rocha, et al.
Annals of the American Thoracic Society|November 15, 2018
Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific CommitteeGerard J Criner, Fernando J Martinez, Shawn Aaron, et al.
Allergy|February 18, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Claudio Rocha, Jessica Beltran, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2026
Airway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical TrialsChristopher B Bosma, Shawn D Aaron, Bartolome R Celli, et al.
ERJ Open Research|September 23, 2020
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocolAlexander G Mathioudakis, Fekri Abroug, Alvar Agusti, et al.
The European Respiratory Journal|October 15, 2021
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbationsAlexander G Mathioudakis, Fekri Abroug, Alvar Agusti, et al.
The European Respiratory Journal|October 14, 2024
Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomicsNazanin Zounemat Kermani, Kian Fan Chung, Giuseppe Macis, et al.
Pageof 43

Showing results (411-420 of 430) with videos related to

Sort By:
Pageof 43
Nature Medicine|February 5, 2008
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationNathan W Bartlett, Ross P Walton, Michael R Edwards, et al.
Allergy|June 3, 2020
EAACI Biologicals Guidelines-Recommendations for severe asthmaIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|February 9, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Jessica Beltran, Cezmi Akdis, et al.
Allergy|March 11, 2020
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthmaIoana Agache, Yang Song, Claudio Rocha, et al.
Annals of the American Thoracic Society|November 15, 2018
Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific CommitteeGerard J Criner, Fernando J Martinez, Shawn Aaron, et al.
Allergy|February 18, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Claudio Rocha, Jessica Beltran, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2026
Airway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical TrialsChristopher B Bosma, Shawn D Aaron, Bartolome R Celli, et al.
ERJ Open Research|September 23, 2020
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocolAlexander G Mathioudakis, Fekri Abroug, Alvar Agusti, et al.
The European Respiratory Journal|October 15, 2021
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbationsAlexander G Mathioudakis, Fekri Abroug, Alvar Agusti, et al.
The European Respiratory Journal|October 14, 2024
Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomicsNazanin Zounemat Kermani, Kian Fan Chung, Giuseppe Macis, et al.
Pageof 43